Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4973145 | 0.88 | TRPV1 (0.59) | TRPV1MAPK3 | |
| SCHEMBL4917766 | 0.84 | TRPV1 (0.59) | TRPV1 | |
| SCHEMBL4919625 | 0.81 | TRPV1 (0.51) | TRPV1 | |
| SCHEMBL6447318 | 0.79 | TRPV1 (0.47) | TRPV1MAPK3 | |
| SCHEMBL5108400 | 0.78 | TRPV1 (0.60) | TRPV1MAPK3 | |
| SCHEMBL27600557 | 0.78 | TRPV1 (0.56) | TRPV1 | |
| SCHEMBL4977671 | 0.78 | TRPV1 (0.57) | TRPV1MAPK3 | |
| SCHEMBL4976316 | 0.77 | TRPV1 (0.44) | TRPV1 | |
| SCHEMBL5115543 | 0.77 | TRPV1 (0.69) | TRPV1MAPK3 | |
| SCHEMBL4911237 | 0.76 | TRPV1 (0.73) | TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1581225-A1 | COMBINATION THERAPY FOR THE TREATMENT OF PAIN | NEUROGEN CORPORATION (US) | 2005-10-05 | — | — | EP | disclosed |
| WO-2004054582-A1 | COMBINATION THERAPY FOR THE TREATMENT OF PAIN | NEUROGEN CORPORATION (US) | 2004-07-01 | — | — | WO | disclosed |